Mercer Global Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Buy |
+13,376
| New | +$238K | ﹤0.01% | 1961 |
|
|
2022
Q2 | – | Sell |
-3,267
| Closed | -$271K | – | 1890 |
|
|
2022
Q1 | $271K | Buy |
3,267
+496
| +18% | +$41.1K | ﹤0.01% | 1564 |
|
|
2021
Q4 | $208K | Sell |
2,771
-321
| -10% | -$24.1K | ﹤0.01% | 1636 |
|
|
2021
Q3 | $359K | Buy |
3,092
+239
| +8% | +$27.7K | ﹤0.01% | 1339 |
|
|
2021
Q2 | $633K | Buy |
2,853
+697
| +32% | +$155K | ﹤0.01% | 1031 |
|
|
2021
Q1 | $285K | Buy |
+2,156
| New | +$285K | ﹤0.01% | 1330 |
|